Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Eiji Miyoshi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9430-2362; OpenAlex author ID A5080369708, A5134315712. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 13

  1. Enterococcus faecalis is involved in the progression of the early stages of latent chronic pancreatitis surrounding pancreatic cancer tissue Last author DOI 10.64898/2026.07.20.739687↗
  2. Prohaptoglobin Promotes Pancreatic Cancer Progression by sustaining YAP Activity Last author DOI 10.64898/2026.07.26.740853↗
  3. Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism. Last author DOI 10.1007/s10719-020-09970-8↗
  4. Evaluation of fatty pancreas by proton density fat fraction using 3-T magnetic resonance imaging and its association with pancreatic cancer. Co-author DOI 10.1016/j.ejrad.2019.06.024↗
  5. Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis. Last author DOI 10.1016/j.cca.2018.09.001↗
  6. Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA system. Last author DOI 10.1007/s10719-017-9772-9↗
  7. Fatty Acid-Mediated Stromal Reprogramming of Pancreatic Stellate Cells Induces Inflammation and Fibrosis That Fuels Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000943↗
  8. A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal epitopes. Co-author DOI 10.1371/journal.pone.0184901↗
  9. Application of glycoscience to the early detection of pancreatic cancer. Co-author DOI 10.1111/cas.13011↗
  10. Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000205↗
  11. Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells. Co-author DOI 10.3892/ijo.2014.2717↗
  12. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma. Last author DOI 10.1097/mpa.0000000000000159↗
  13. Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer. First author DOI 10.1111/cas.12084↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hidetoshi Eguchi · 10 shared papers, 2013–2026 · strength 1.04
  2. Hirofumi Akita · 5 shared papers, 2015–2026 · strength 0.73
  3. Yoshihiro Kamada · 7 shared papers, 2014–2026 · strength 0.72
  4. Jumpei Kondo · 2 shared papers, 2026 · strength 0.54
  5. Daisaku Yamada · 4 shared papers, 2017–2026 · strength 0.43
  6. Kaho Nishikori · 1 shared paper, 2026 · strength 0.24
  7. Yuichiro Doki · 5 shared papers, 2013–2017 · strength 0.23
  8. Masahiro Tanemura · 5 shared papers, 2013–2017 · strength 0.22
  9. Koichi Morishita · 2 shared papers, 2018–2021 · strength 0.19
  10. Nami Ito · 2 shared papers, 2018–2021 · strength 0.19
  11. Hiroaki Nagano · 4 shared papers, 2013–2017 · strength 0.17
  12. Kenta Furukawa · 3 shared papers, 2015–2017 · strength 0.14
  13. Tadafumi Asaoka · 2 shared papers, 2017 · strength 0.11
  14. Soichiro Mori · 1 shared paper, 2021 · strength 0.11
  15. Noriyuki Tomiyama · 1 shared paper, 2019 · strength 0.08
  16. Yasunari Fukuda · 1 shared paper, 2019 · strength 0.08
  17. Hideyuki Fukui · 1 shared paper, 2019 · strength 0.08
  18. Tsukasa Tanida · 2 shared papers, 2015 · strength 0.08
  19. Ken Kusama · 1 shared paper, 2017 · strength 0.07
  20. Tomoki Hata · 1 shared paper, 2017 · strength 0.06
  21. Masaki Mori · 1 shared paper, 2017 · strength 0.06
  22. Yoshifumi Iwagami · 1 shared paper, 2017 · strength 0.06
  23. Kunihito Gotoh · 1 shared paper, 2017 · strength 0.06
  24. Atsushi Masamune · 1 shared paper, 2017 · strength 0.06
  25. Yasuhiko Tomita · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.